Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNECTICS PLC Director's Dealing 2021

Oct 1, 2021

7942_dirs_2021-10-01_75bfe465-5d1c-41df-9cec-80dfa6290cd3.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7847N

Synectics PLC

01 October 2021

## RNS ## 1 October 2021

Synectics plc

("Synectics" or the "Company")

Director/PDMR dealings

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that earlier today, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 14,843 ordinary shares of 20 pence each in the Company at a price of £1.05 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2021.

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period which was £1.35.

As a result of this purchase, the Company has been notified that the following Executive Directors and PDMRs have acquired the following interests in shares of the Company:

Name Position Status Number of Shares purchased by the Trustee
Paul Webb Chief Executive Executive Director 857
David Bedford Finance Director Executive Director 857
Greg Alcorn Divisional Director PDMR 857
David Lowe Divisional Director PDMR 857

In addition, David Bedford, Finance Director of the Company has notified the Company that he too purchased 5,000 ordinary shares of 20p each in the Company at £1.05 per share earlier today.

Following these purchases, the interests of Messrs Webb, Bedford, Alcorn and Lowe in the shares of the Company are as follows:

Name Shares Held Interest in Shares in Share Schemes Resultant Total Interest % of Issued Share Capital
Paul Webb 57,115 536,327 593,442 3.33%
David Bedford 20,000 186,857 206,857 1.16%
Greg Alcorn - 25,655 25,655 0.14%
David Lowe 15,000 43,177 58,177 0.33%

For further information, please contact:

Synectics plc Tel: +44 (0) 114 280 2828
Claire Stewart, Company Secretary
email: [email protected] www.synecticsplc.com
Shore Capital Tel: +44 (0) 20 7408 4050
Tom Griffiths / David Coaten / Henry Willcocks

Ends

About Synectics plc

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

Find out more at www.synecticsplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEADEFEFLFFFA